Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
Pediatr Allergy Immunol
; 33(1): e13682, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34669990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peanut Hypersensitivity
/
Omalizumab
Limits:
Humans
Language:
En
Journal:
Pediatr Allergy Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
/
PEDIATRIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: